Launch of new Prostate Cancer Knowledge Centre for doctors

Jan. 6, 2011 - PRLog -- The launch of a new interactive online ‘Knowledge Centre’ on Prostate Cancer has been announced by EPG Health Media. The Prostate Cancer Knowledge Centre is designed to support healthcare professionals involved in the management of patients with prostate cancer. Healthcare professionals are invited to access the resource for free at EPG Online (www.epgonline.org/prostate-cancer).

Globally, at least 605,000 people are diagnosed with prostate cancer each year.1 The regional incidence of prostate cancer varies widely, with some of the highest rates observed in Northern and Western Europe, North America, Australia and New Zealand.2 In Europe, prostate cancer is the most frequently diagnosed non-skin cancer in men, accounting for one in five male cancers.3

Sponsored by Astellas Pharma Europe Ltd., the Prostate Cancer Knowledge Centre includes a comprehensive review of diagnostic approaches to prostate cancer, staging of the disease and treatment options including a particular focus on hormonal therapy.

“The current challenges faced by healthcare professionals dealing with prostate cancer patients are to identify those patients who will benefit from therapy and decide on the best course of treatment.” said Chris Cooper, EPG Health Media. “By working with our partner Astellas, we aim to provide our doctors with a resource that supports them in making these important decisions.”

“Astellas is a strong supporter of medical education. Working with EPG on this timely prostate cancer knowledge website is one of many ways that we assist the healthcare community.” said Txema Sanz D. Phil, Astellas Pharma Europe Ltd.

Established in 2000, EPG Online is an independent website, dedicated to providing healthcare professionals with free access to the most recent best practice diagnosis and patient management guidance. In addition to more than twenty disease Knowledge Centres, EPG Online includes a databases of prescription drugs in 9 European languages (searchable by name and indication), clinical trial reports and treatment guidelines.

With over 300,000 members and more than 110,000 pages of clinical content, EPG Online represents the largest and most widely subscribed to disease, medicines and free educational platform for European doctors. The website is operated by EPG Health Media, an online health publisher dedicated to providing a concise and extensive learning platform to inform and educate doctors in Europe and beyond.  

Astellas Pharma Europe Ltd., located in the UK, is a European subsidiary of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceuticals. The organisation is committed to becoming a global company by combining outstanding R&D and marketing capabilities and continuing to grow in the world pharmaceutical market. Astellas Pharma Europe Ltd. is responsible for 20 affiliate offices located across Europe, the Middle East and Africa, an R&D site and three manufacturing plants. The company employs approximately 3,800 staff across these regions.  For more information about Astellas Pharma Europe, please visit www.astellas.eu.


References
1. World Health Organization. The global burden of disease: 2004 update. Geneva: WHO, 2004.
2. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
3. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92.

# # #

About EPG Health Media:
Established in 1998, EPG Health Media is an innovative communications business with competencies in digital publishing, digital communications consultancy and market reasearch. The company's unique service offering provides healthcare information providers with geotargeted online access to healthcare professionals and patients across Europe and globally.